المؤلفون: Wambaugh MA; Division of Microbiology and Immunology, Pathology Department, University of Utah School of Medicine, Salt Lake City, United States., Denham ST; Division of Microbiology and Immunology, Pathology Department, University of Utah School of Medicine, Salt Lake City, United States., Ayala M; Division of Microbiology and Immunology, Pathology Department, University of Utah School of Medicine, Salt Lake City, United States., Brammer B; Division of Microbiology and Immunology, Pathology Department, University of Utah School of Medicine, Salt Lake City, United States., Stonhill MA; Division of Microbiology and Immunology, Pathology Department, University of Utah School of Medicine, Salt Lake City, United States., Brown JC; Division of Microbiology and Immunology, Pathology Department, University of Utah School of Medicine, Salt Lake City, United States.

المصدر: ELife [Elife] 2020 May 05; Vol. 9. Date of Electronic Publication: 2020 May 05.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE

مواضيع طبية MeSH: Drug Antagonism* , Drug Synergism*, Antifungal Agents/*therapeutic use , Mycoses/*drug therapy, Animals ; Antifungal Agents/pharmacology ; Cryptococcosis/drug therapy ; Cryptococcus neoformans/drug effects ; Drug Evaluation, Preclinical ; Female ; Fluconazole/pharmacology ; Fluconazole/therapeutic use ; High-Throughput Screening Assays ; Humans ; Meningitis, Cryptococcal/drug therapy ; Mice ; Structure-Activity Relationship